Bausch Health Companies (BHC) Cash & Current Investments (2009 - 2026)

Bausch Health Companies (BHC) has 18 years of Cash & Current Investments data on file, last reported at $1.3 billion in Q1 2026.

• For the quarter ending Q1 2026, Cash & Current Investments rose 13.4% year-over-year to $1.3 billion; the trailing twelve-month figure through Mar 2026 stood at $1.3 billion (up 13.4% YoY), and the FY2025 full-year result was $1.3 billion, up 10.32% from the prior year.
• Cash & Current Investments fell to $1.3 billion in Q1 2026, from $1.3 billion in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $2.5 billion in Q1 2022 to a low of $497.0 million in Q3 2022.
• A 5-year average of $1.1 billion and a median of $962.0 million in 2023 frame the typical range for Cash & Current Investments.
• Across the five-year window, Cash & Current Investments tumbled 78.41% in 2023 and surged 179.78% in 2025, its largest moves.
• Tracing BHC's Cash & Current Investments over 5 years: stood at $591.0 million in 2022, then soared by 62.77% to $962.0 million in 2023, then gained by 24.84% to $1.2 billion in 2024, then climbed by 10.32% to $1.3 billion in 2025, then fell by 0.98% to $1.3 billion in 2026.
• Business Quant data shows BHC's Cash & Current Investments at $1.3 billion in Q1 2026, $1.3 billion in Q4 2025, and $1.3 billion in Q3 2025.